CD38 Deficiency Protects Mouse Retinal Ganglion Cells Through Activating the NAD+/Sirt1 Pathway in Ischemia-Reperfusion and Optic Nerve Crush Models

Author:

Pang Yulian1,Hu Haijian1,Xu Ke1,Cao Ting123,Wang Zhiruo14,Nie Jiahe15,Zheng Haina1,Luo Hongdou1,Wang Feifei1,Xiong Chan1,Deng Ke-Yu6,Xin Hong-Bo6,Zhang Xu1

Affiliation:

1. Affiliated Eye Hospital of Nanchang University, Jiangxi Medical College, Nanchang University, Jiangxi Research Institute of Ophthalmology and Visual Science, Jiangxi Provincial Key Laboratory for Ophthalmology, Jiangxi Clinical Research Center for Ophthalmic Disease, Nanchang, China

2. Department of Orthopaedics, The Fourth Medical Center of Chinese PLA General Hospital, Beijing, China

3. Medical School of Chinese PLA, Beijing, China

4. Department of Ophthalmology, The Second Xiangya Hospital of Central South University, Changsha, China

5. State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangzhou, China

6. Institute of Translational Medicine, Nanchang University, Nanchang, China

Publisher

Association for Research in Vision and Ophthalmology (ARVO)

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Potential Therapeutic Interventions Targeting NAD+ Metabolism for ALS;Cells;2024-09-09

2. The role of SIRT1 in kidney diseases;International Urology and Nephrology;2024-07-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3